Examples include Tauopathies, described in frontotemporal dementia (FTD) and Alzheimer’s disease (AD), and characterized by accumulation of aberrant Tau proteins (Morris et al., 2011; Gotz et al., 2013; Wang et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.